COVID-19 Update: Trump's New Consultant, Plasma Possible

featured image

Editor’s note: Discover the most current COVID-19 news and assistance in Medscape’s Coronavirus Resource.

Here are the coronavirus stories Medscape’s editors around the globe believe you need to understand about today:

Trump’s New Advisor

.

President Trump last week added a new medical consultant to the White House’s coronavirus response: Scott Atlas, MD, a senior fellow at Stanford University’s Hoover Organization, a conservative think tank. His views are lined up carefully with Trump’s views on the virus, especially with regard to reopening schools, avoiding lockdowns, and resuming some sports.

Atlas is board-certified in diagnostic radiology and acted as a professor and chief of neuroradiology at Stanford University Medical Center in California from 1998 to2012 He has likewise worked as a medical advisor for Republican governmental prospects consisting of Mitt Romney.

Plasma Prospective

.

Researchers from the Mayo Center recently reported the results for 35,000 COVID-19 clients who got convalescent plasma through the US Food and Drug Administration (FDA) broadened access program. The outcomes “supply signatures of effectiveness,” they compose in the report published to the preprint server medRxiv.org, though the research study was observational and did not have a control group.

More than 64,000 COVID-19 patients in the US have currently received convalescent plasma as a possible treatment, however experts worry it will be hard to learn whether the intervention overcomes clinical trials. “There’s concern about when there will be a clear response,” one contagious disease expert told the Associated Press.

Skin Lesions From Infection or Treatment?

.

SARS-CoV-2 infection has actually been connected with a range of skin problem, however the substance abuse to deal with COVID-19 can also have cutaneous adverse effects, skin doctors write in an evaluation

Diagnosing skin symptoms in clients with COVID-19 stays a difficulty, since it is uncertain whether the skin sores relate to the infection, the authors compose. They advise that skin specialists think about adverse drug reactions in the differential diagnosis also.

PPE Lack Could Ins 2015

.

Officials from healthcare and manufacturing industries predict that shortages of individual protective equipment (PPE) and medical materials could continue for many years without strategic government intervention, Kaiser Health News reports

Producers in the National Council of Fabric Organizations, that make recyclable fabric dress, have made “hundreds of countless items,” said CEO Kim Glas, however without long-lasting government agreements, many are worried to invest in the devices required to scale up the business and eventually lower rates.

” If there continues to be an upward trajectory of COVID-19 cases, not just in the United States however internationally, you can see those supply chains breaking down again,” Glas said. “It is a healthcare security concern.”

US to Make Coronavirus Strain for Possible Human Obstacle Trials

.

United States federal government scientists have started efforts to manufacture a strain of SARS-CoV-2 that could be utilized in human difficulty trials of vaccines, in which healthy volunteers would be vaccinated and after that deliberately infected with the virus, Reuters reports

The work is initial and such trials would not change phase 3 trials such as those now under way screening speculative COVID-19 vaccines from Moderna and Pfizer, according to a statement from the National Institute of Allergy and Transmittable Illness (NIAID).

” Ought to there be a need for human difficulty research studies to totally evaluate candidate vaccines or rehabs for SARS-CoV-2, NIAID has started examinations of the technical and ethical factors to consider of conducting human difficulty research studies,” the firm’s statement stated.

FDA Authorizes New Saliva Test

.

The FDA authorized a new type of saliva-based COVID-19 test on Saturday, which could reduce the cost of testing and the time it requires to process results.

The diagnostic test, created by the Yale School of Public Health and called SalivaDirect, does not need a special type of swab or collection tube, and also doesn’t require an unique type of extractor, which is helpful because the extraction sets utilized to process other tests have dealt with shortages during the pandemic.

Yale will supply the directions to laboratories as an open source procedure. The test does not need any proprietary equipment or testing parts, so laboratories throughout the nation can put together and use it based on the FDA guidelines. The testing technique is offered immediately and might be scaled up quickly in the next couple of weeks, according to a statement from Yale.

Speculative Botanical Discussed

.

President Trump met the vice chairman and director of a biotech business, together with secretary of Housing and Urban Development Ben Carson, MD, and MyPillow founder/CEO Mike Lindell, a financier in the business, to become aware of its speculative botanical extract oleandrin that the vice chairman says is a “cure” for COVID-19, Axios reported

In a preprint published to the server bioRxiv.org last month, researchers from the University of Texas Medical Branch at Galveston and Phoenix Biotechnology, the company establishing oleandrin, stated the compound showed “potent prophylactic and restorative antiviral activities” in cultures of Vero cells. More clinical studies have actually not been released.

According to Axios, Phoenix Biotechnology vice chairman Andrew Whitney said the company is pursuing FDA permission for oleandrin as a drug for COVID-19, or consent to sell it as a dietary supplement, and Trump has actually supposedly “expressed interest” about the extract.

In Memoriam

.

Medscape has published a memorial list to commemorate them.

If you would like to share any other experiences, stories, or concerns related to the pandemic, please sign up with the conversation here

Ellie Kincaid is Medscape’s associate handling editor.

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube, and follow Ellie Kincaid on Twitter @ellie_kincaid.

Here’s how to send Medscape a story tip.

Find Out More

https://covid19globalcases.com/covid-19-update-trumps-new-consultant-plasma-possible/

Comments